New York Hospital Halts Care for Two Transgender Children Post Trump’s Policy Directive

New York Hospital Halts Care for Two Transgender Children Post Trump’s Policy Directive

Amidst an executive directive from President Trump warning against gender-affirming practices, a prominent hospital in New York City has ceased treatment for two transgender minors.

Parents have reported that NYU Langone Health, a major medical institution, discreetly started canceling appointments intended for transgender youth, right after a policy from the Trump administration posed the threat of cutting federal support for hospitals engaging in gender-affirmative procedures.

The notifications of cancellation were shared among families when two 12-year-olds’ scheduled treatments, which involved the insertion of puberty blocker-releasing implants, were abruptly terminated.

One of the children's fathers explained that his child’s pediatric specialist attributed the action to “the new governing authorities,” implicitly referencing Trump’s policy. His child had been set to receive an implant designed to dispense Supprelin LA, a medication inhibiting puberty, on Thursday. The doctor mentioned possibly seeking assistance from other medical systems in New York City or a recommended facility in Philadelphia.

The second youth's procedure was set for Friday, but the child’s parent was informed of the cancellation the Wednesday preceding the planned intervention, just a day after the new policy was declared. Upon questioning, she was told the medical staff was “awaiting further instructions.”

Steve Ritea, acting as the spokesperson for NYU Langone Health, refrained from offering comments, noting a lack of specific information that could be disclosed. NYU Langone is among several significant healthcare facilities in the area running programs for transgender youth health services. According to a recent study, approximately 1.8% of young people aged 13 to 17 in New York State identify as transgender, a figure nearly double the national rate.

The executive order in question forms part of a series of actions by President Trump in his early weeks aiming to regulate medical care related to gender and transgender issues. This particular order challenges medical practitioners and hospitals providing gender-affirming treatment to those under 19, which includes puberty blockers, hormones, and surgical options.

Leave a Reply

Your email address will not be published. Required fields are marked *

Related Posts